Jefferies Financial Group Inc. Acquires 23,362 Shares of GE HealthCare Technologies Inc. $GEHC

Jefferies Financial Group Inc. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 27.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 107,396 shares of the company’s stock after purchasing an additional 23,362 shares during the period. Jefferies Financial Group Inc.’s holdings in GE HealthCare Technologies were worth $8,065,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Wedge Capital Management L L P NC purchased a new position in GE HealthCare Technologies in the third quarter valued at approximately $26,859,000. Valicenti Advisory Services Inc. increased its position in GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares during the last quarter. Locust Wood Capital Advisers LLC increased its position in GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after buying an additional 137,992 shares during the last quarter. Nan Fung Trinity HK Ltd. bought a new stake in shares of GE HealthCare Technologies in the third quarter valued at $23,206,000. Finally, Envestnet Asset Management Inc. lifted its position in shares of GE HealthCare Technologies by 15.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after buying an additional 46,231 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $75.63 on Tuesday. The firm has a fifty day simple moving average of $81.66 and a two-hundred day simple moving average of $78.62. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77. The company has a market capitalization of $34.47 billion, a PE ratio of 16.59, a P/E/G ratio of 1.63 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

Wall Street Analyst Weigh In

Several equities research analysts have commented on GEHC shares. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Citigroup boosted their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price objective for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Evercore lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Finally, Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.